China Telecom subsidiary says AI wave drives steady growth in digital services market


China Communication Services, the country’s leading telecommunications infrastructure contractor, said a wave of artificial intelligence projects is now driving digital transformation in thousands of industries and providing a boost to the company’s three major business segments.
Beijing-based China Comservice, a subsidiary of China Telecom, made that assessment on Thursday as the firm reported its latest financial results, which showed growth in both revenue and net profit in the first six months of the year.
The Hong Kong-listed company reported a 3.4 per cent year-on-year increase in revenue to 76.94 billion yuan (US$10.71 billion), while net profit rose a modest 0.2 per cent to 2.13 billion yuan.

“AI has a significant effect in driving the development of the company’s various businesses,” said Luan Xiaowei, executive director and chairman at China Comservice.

Shares of China Comservice closed up 2.10 per cent to HK$4.86 on Thursday.

The applications, content and other services business segment remains the core driver of revenue growth for China Comservice. Photo: Handout
The applications, content and other services business segment remains the core driver of revenue growth for China Comservice. Photo: Handout

The company’s latest interim results reflect how it continued to benefit from AI application projects and heightened demand for digital transformation across thousands of industries on the mainland, it said.

  • Related Posts

    Brazil’s visa-free entry for Chinese visitors sparks rise in South America travel demand

    Travel agencies are seeing a notable rise in inquiries and bookings for trips to South America by tourists from mainland China after Brazil’s visa-free entry policy for visitors from the…

    Continue reading
    China’s Hengrui seals US$15.2 billion deal with US pharmaceutical giant BMS

    Jiangsu Hengrui Pharmaceutical, China’s largest drug company by market capitalisation, has signed a global collaboration and licensing agreement with US pharmaceutical giant Bristol Myers Squibb (BMS) worth up to US$15.2…

    Continue reading

    Leave a Reply

    Your email address will not be published. Required fields are marked *